Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
© 2017 Rho kinase inhibitors (ROCK II) play a key role in glaucoma management attributed to their IOP lowering ability and neuroprotective effects. In the present study, a series of novel benzimidazole derivatives (9a–m) has been synthesized and evaluated for their IOP lowering, Rho kinase inhibi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Pergamon
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/73263 |